Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2017

May 9, 2017

284_dirs_2017-05-09_dc636b6b-5759-4487-9c56-150a92b2dd6e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2017-05-05

Reporting Person: GRADDICK WEIR MIRIAN M (Exe V-P, HR)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-05-05 Stock Option (right to buy) $63.9700 A 72753.0000 Acquired 2027-05-04 Common Stock (72753.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 106484.3190 Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.